Daniel Tereau - PerkinElmer President
PKIDelisted Stock | USD 115.24 0.74 0.64% |
President
Mr. Daniel R. Tereau JD. is Senior Vice President, Strategy and Business Development of the Company. Mr. Tereau was appointed Senior Vice President, Strategy and Business Development in January 2016, having joined the Company in April 2014 as Vice President, Strategy and Business Development. He is responsible for leading PerkinElmers overall strategic planning and business development activities. Prior to joining PerkinElmer, Mr. Tereau served on Novartis leadership team as Senior Vice President and Global Head of Strategy, Business Development and Licensing from 2011 to 2014, where he was responsible for global strategy and business development for the Consumer Health division. Prior to 2011, Mr. Tereau held similar roles at Thermo Fisher Scientific and GE Healthcare since 2016.
Age | 55 |
Tenure | 8 years |
Professional Marks | MBA |
Phone | 781 663 6900 |
Web | https://www.perkinelmer.com |
PerkinElmer Management Efficiency
The company has Return on Asset of 0.0369 % which means that on every $100 spent on assets, it made $0.0369 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0706 %, implying that it generated $0.0706 on every 100 dollars invested. PerkinElmer's management efficiency ratios could be used to measure how well PerkinElmer manages its routine affairs as well as how well it operates its assets and liabilities.The company has 3.92 B in debt with debt to equity (D/E) ratio of 0.65, which is OK given its current industry classification. PerkinElmer has a current ratio of 1.98, which is typical for the industry and considered as normal. Debt can assist PerkinElmer until it has trouble settling it off, either with new capital or with free cash flow. So, PerkinElmer's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like PerkinElmer sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for PerkinElmer to invest in growth at high rates of return. When we think about PerkinElmer's use of debt, we should always consider it together with cash and equity.
Similar Executives
Showing other executives | PRESIDENT Age | ||
Michael Rutz | Sotera Health Co | 53 | |
Matthew Gugino | Danaher | N/A | |
Robert Carson | Waters | 46 | |
Gregory Herrema | Thermo Fisher Scientific | 52 | |
Pat Venters | IDEXX Laboratories | N/A | |
Paula Dowdy | Illumina | N/A | |
Patrick Durbin | Thermo Fisher Scientific | 51 | |
Davide Molho | Charles River Laboratories | 47 | |
Michael Harrington | Waters | 59 | |
Stephen Williamson | Thermo Fisher Scientific | 57 | |
Michael Tang | Agilent Technologies | 50 | |
Daniel Comas | Danaher | 55 | |
Samuel Eberts | Laboratory of | 57 | |
Jon Resnick | IQVIA Holdings | N/A | |
Michael Boxer | Thermo Fisher Scientific | 58 | |
Sharon Underberg | IDEXX Laboratories | 63 | |
Samraat Raha | Agilent Technologies | 51 | |
Eric Sherbet | IQVIA Holdings | 60 | |
Sanjay Chikarmane | Illumina | N/A | |
Daniel Shine | Thermo Fisher Scientific | 47 | |
Sam Samad | Illumina | 48 |
Management Performance
Return On Equity | 0.0706 | |||
Return On Asset | 0.0369 |
PerkinElmer Leadership Team
Elected by the shareholders, the PerkinElmer's board of directors comprises two types of representatives: PerkinElmer inside directors who are chosen from within the company, and outside directors, selected externally and held independent of PerkinElmer. The board's role is to monitor PerkinElmer's management team and ensure that shareholders' interests are well served. PerkinElmer's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, PerkinElmer's outside directors are responsible for providing unbiased perspectives on the board's policies.
Michel Vounatsos, Independent Director | ||
Sylvie Gregoire, Independent Director | ||
Pascale Witz, Independent Director | ||
Miriame Victor, Chief Commercial Officer, Senior Vice President | ||
Jonathan DiVincenzo, Sr. VP and President of Environmental Health | ||
Patrick Sullivan, Independent Director | ||
Stephen Willoughby, VP ESG | ||
Tajinder Vohra, Senior Vice President Global Operations | ||
Prahlad Singh, Senior Vice President and President - Diagnostics | ||
Robert Friel, Chairman, CEO and President and Member of Fin. Committee | ||
Vicki Sato, Independent Director | ||
Maxwell Krakowiak, VP CFO | ||
Daniel Tereau, Senior Vice President Strategy and Business Development | ||
Alexandros Michas, Independent Non-Executive Chairman of the Board | ||
Nicholas Lopardo, Lead Independent Director | ||
Franklin Witney, Director | ||
Joel Goldberg, Senior Vice President - Administration, General Counsel, Secretary | ||
James Corbett, Sr. VP and President of Human Health | ||
Kenton Sicchitano, Independent Director | ||
Samuel Chapin, Independent Director | ||
James Mock, Chief Financial Officer, Senior Vice President | ||
Andrew Okun, Chief Accounting Officer, Vice President, Treasurer | ||
Peter Barrett, Independent Director | ||
Deborah Butters, Chief Human Resource Officer, Senior Vice President | ||
Frank Witney, Independent Director | ||
John Letcher, Senior Vice President - Human Resources | ||
Alexis Michas, Independent Non-Executive Chairman of the Board | ||
Jon DiVincenzo, Senior Vice President and Presidentident - Environmental Health | ||
Masoud Toloue, VP Diagnostics | ||
Frank Wilson, CFO and Sr. VP |
PerkinElmer Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is PerkinElmer a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.0706 | |||
Return On Asset | 0.0369 | |||
Profit Margin | 0.17 % | |||
Operating Margin | 0.26 % | |||
Current Valuation | 22.3 B | |||
Shares Outstanding | 126.41 M | |||
Shares Owned By Insiders | 0.26 % | |||
Shares Owned By Institutions | 86.25 % | |||
Number Of Shares Shorted | 3.53 M | |||
Price To Earning | 21.07 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards PerkinElmer in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, PerkinElmer's short interest history, or implied volatility extrapolated from PerkinElmer options trading.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as PerkinElmer using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Consideration for investing in PerkinElmer Stock
If you are still planning to invest in PerkinElmer check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PerkinElmer's history and understand the potential risks before investing.
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |